STOCK TITAN

Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results

Avanos Medical, Inc. (NYSE: AVNS) will hold a conference call on Feb. 23, 2022, at 9 a.m. ET, to discuss its fourth quarter and full year 2021 financial results.

(Neutral)
(Neutral)
Tags
conferences earnings

Rhea-AI Summary

Avanos Medical, Inc. (NYSE: AVNS) will hold a conference call on Feb. 23, 2022, at 9 a.m. ET, to discuss its fourth quarter and full year 2021 financial results. A news release with these results will be issued before the market opens on that day. The call will be led by CEO Joe Woody and CFO Michael Greiner. Participants can access the call by dialing 877-240-5772 in the U.S., with a webcast available through the company’s investor website. A replay will be accessible later that day and for one week following the call.

Loading...
Loading translation...

Positive

  • Scheduled conference call to discuss 2021 financial results showcases transparency.
  • Webcast and replay options enhance accessibility for investors.

Negative

  • None.
Argus Session date unavailable
+2.08% session move Open Argus
Details

News Market Reaction – AVNS

The recorded move for AVNS in the trading session of this news was +2.08%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ALPHARETTA, Ga., Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2021 on Wednesday, Feb. 23 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.

The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer.

To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call and a related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/.

A replay of the conference call will be available Feb. 23 at noon ET by dialing 877-344-7529 in the United States and entering passcode 10161855. It will be available for one week. A replay of the webcast also will be accessible in the Investors section of the website, approximately one hour following the completion of the conference call.

About Avanos Medical, Inc.
Avanos Medical (NYSE: AVNS) is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-fourth-quarter-and-full-year-2021-financial-results-301482803.html

SOURCE Avanos Medical, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What date will Avanos Medical's fourth quarter and full year 2021 financial results be discussed?

Avanos Medical will discuss its financial results on Feb. 23, 2022.

Who will host the Avanos Medical conference call?

The conference call will be hosted by Joe Woody, CEO, and Michael Greiner, CFO.

How can I access the Avanos Medical conference call?

Dial 877-240-5772 in the U.S. or listen via the webcast on the company's investor website.

Will there be a replay of the conference call?

Yes, a replay will be available on Feb. 23 after noon ET for one week.

Keep reading